Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
XPOVIO® (selinexor) Approved for New Indication in DLBCL in China, Bringing a New Treatment Option to Patients in the Country 2024-07-05 21:18
Hinova Pharmaceuticals receives FDA Fast Track Designation for HP518 for Treatment of AR+ Triple-Negative Breast Cancer (TNBC) 2024-07-05 21:00
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition 2024-07-05 19:00
IASO Bio and Innovent Enhance Strategic Collaboration in Cell Therapy 2024-07-05 16:30
Innovent and IASO Bio Enhance Strategic Collaboration in Cell Therapy 2024-07-05 16:30
Biostar Pharma Announces FDA Clearance of the IND Application for a Phase 2 Study of Utidelone Injection (UTD1) in HER2- Breast Cancer Brain Metastasis 2024-07-05 16:07
Zhejiang Doer Biologics Completes Enrollment of the Phase 1b/2a Trial Evaluating DR10624 in Obese Subjects with Modest Hypertriglyceridemia 2024-07-05 15:56
LOTTE BIOLOGICS Holds Groundbreaking for Songdo Bio Campus 2024-07-04 11:17
Ascentage Pharma Received US$100 Million Option Payment from Takeda 2024-07-04 08:28
/C O R R E C T I O N -- Menarini Silicon Biosystems/ 2024-07-03 03:24
Bloomage Ranks on World Brand Lab's China 500 Most Valuable Brands List 2024-07-02 21:00
PharmAbcine's Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration Advances to Both Single-dose of 4mg and Multiple-dose of 3mg 2024-07-02 11:02
HiRO acquires CRO DeltaMed Solutions, continues to expand cross-border operations in the US 2024-07-02 10:00
Innovent Announces Oral Presentation at the ESMO Gastrointestinal Cancers Congress 2024 on Latest Clinical Data of Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma 2024-07-02 08:00
Altos Biologics Files for Approval of Aflibercept Biosimilar 2024-07-02 08:00
Bridgewest Perth Pharma gains strategic edge with noted Australian Executive John Van Der Wielen on Board 2024-07-02 07:00
IASO Bio Presented Clinical Data and Single-cell Analysis of Equecabtagene Autoleucel for the Treatment of Central Nervous System Autoimmunity in Oral Presentation at EAN Congress 2024 2024-07-01 15:43
SCG Cell Therapy Announces FDA IND Clearance of SCG142, a next-generation HPV-specific TCR T cell therapy for patients with HPV-associated solid tumors 2024-07-01 10:56
Pierre Fabre Laboratories announce granting of European marketing authorization for OBGEMSA™ (vibegron) in overactive bladder. 2024-06-28 23:55
Comprehensively Covering Multiple Myeloma: IASO Bio's GPRC5D CAR-T Product RD118 Receives IND Approval from NMPA 2024-06-28 18:59
1 25 26 27 28 29 412